ESR2 and breast carcinoma: The restoration of ERβ expression in ovarian cancer cells [99] and breast cancer cells [100] results in an increasing apoptosis and a strong inhibition of proliferation and invasion, further supporting the role of ERβ as a tumor suppressor.